USD 0.0
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 407.48 Thousand USD | -58.94% |
2022 | 992.39 Thousand USD | -12.74% |
2021 | 1.13 Million USD | 4053.05% |
2020 | 27.38 Thousand USD | 114.8% |
2019 | 12.74 Thousand USD | -76.87% |
2018 | 55.11 Thousand USD | 0.0% |
2017 | - USD | 0.0% |
2015 | 2.4 Million USD | 7204.81% |
2014 | 32.96 Thousand USD | 211.8% |
2013 | 10.57 Thousand USD | 4.29% |
2012 | 10.13 Thousand USD | -70.65% |
2011 | 34.54 Thousand USD | 172.02% |
2010 | 12.7 Thousand USD | -14.08% |
2009 | 14.78 Thousand USD | -74.67% |
2008 | 58.34 Thousand USD | -20.73% |
2007 | 73.6 Thousand USD | 508.47% |
2006 | -18.01 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 117.06 Thousand USD | -26.71% |
2024 Q1 | 25.66 Thousand USD | 46.59% |
2024 Q2 | 159.73 Thousand USD | 522.43% |
2023 FY | 407.48 Thousand USD | -58.94% |
2023 Q4 | 17.5 Thousand USD | -94.18% |
2023 Q3 | 300.72 Thousand USD | 525.73% |
2023 Q2 | 48.06 Thousand USD | -53.74% |
2023 Q1 | 103.88 Thousand USD | -38.06% |
2022 FY | 992.39 Thousand USD | -12.74% |
2022 Q4 | 167.73 Thousand USD | 22.87% |
2022 Q3 | 136.51 Thousand USD | 0.0% |
2021 FY | 1.13 Million USD | 4053.05% |
2020 FY | 27.38 Thousand USD | 114.8% |
2019 FY | 12.74 Thousand USD | -76.87% |
2018 FY | 55.11 Thousand USD | 0.0% |
2017 FY | - USD | 0.0% |
2016 Q2 | 644.59 Thousand USD | -0.23% |
2016 Q1 | 646.09 Thousand USD | 38.13% |
2015 Q2 | 629.1 Thousand USD | 133.15% |
2015 Q3 | 1.24 Million USD | 97.6% |
2015 Q4 | 467.74 Thousand USD | -62.37% |
2015 Q1 | 269.82 Thousand USD | 1.38% |
2015 FY | 2.4 Million USD | 7204.81% |
2014 Q1 | 2778.00 USD | -46.69% |
2014 FY | 32.96 Thousand USD | 211.8% |
2014 Q3 | 22.35 Thousand USD | 753.72% |
2014 Q2 | 2619.00 USD | -5.72% |
2014 Q4 | 266.15 Thousand USD | 1090.39% |
2013 Q4 | 5211.00 USD | 327.48% |
2013 FY | 10.57 Thousand USD | 4.29% |
2013 Q3 | 1219.00 USD | -49.77% |
2013 Q2 | 2427.00 USD | 1.04% |
2013 Q1 | 2402.00 USD | -46.91% |
2012 Q1 | 2495.00 USD | -5.96% |
2012 Q2 | 2495.00 USD | 0.0% |
2012 Q3 | 2495.00 USD | 0.0% |
2012 Q4 | 4524.00 USD | 81.32% |
2012 FY | 10.13 Thousand USD | -70.65% |
2011 Q4 | 2653.00 USD | -4.19% |
2011 Q1 | 24.54 Thousand USD | 395.22% |
2011 Q2 | 2279.00 USD | -90.71% |
2011 Q3 | 2769.00 USD | 21.5% |
2011 FY | 34.54 Thousand USD | 172.02% |
2010 Q2 | 2402.00 USD | 1.18% |
2010 FY | 12.7 Thousand USD | -14.08% |
2010 Q3 | 2565.00 USD | 6.79% |
2010 Q1 | 2374.00 USD | -55.7% |
2010 Q4 | 4956.00 USD | 93.22% |
2009 Q4 | 5359.00 USD | 100.56% |
2009 Q2 | 2390.00 USD | -1.36% |
2009 Q1 | 2423.00 USD | -66.79% |
2009 FY | 14.78 Thousand USD | -74.67% |
2009 Q3 | 2672.00 USD | 11.8% |
2008 Q4 | 7296.00 USD | 341.27% |
2008 Q2 | 5185.00 USD | -26.43% |
2008 Q1 | 7048.00 USD | -85.66% |
2008 FY | 58.34 Thousand USD | -20.73% |
2008 Q3 | -3024.00 USD | -158.32% |
2007 Q3 | 23.74 Thousand USD | -4.12% |
2007 FY | 73.6 Thousand USD | 508.47% |
2007 Q2 | 24.76 Thousand USD | 147.08% |
2007 Q1 | -52.59 Thousand USD | -958.88% |
2007 Q4 | 49.13 Thousand USD | 106.95% |
2006 Q4 | 6124.00 USD | 0.0% |
2006 FY | -18.01 Thousand USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
CVR Medical Corp. | - USD | -Infinity% |
BioElectronics Corporation | 740.67 Thousand USD | 44.985% |
IR-Med Inc. | 4.89 Million USD | 91.674% |
Polarean Imaging plc | 12.24 Million USD | 96.672% |
Medical Supply International USA, Inc. | 1.32 Million USD | 69.142% |
Avitar, Inc. | 3.56 Million USD | 88.584% |
AVITA Medical, Inc. | 80.77 Million USD | 99.496% |
Manhattan Scientifics, Inc. | 703 Thousand USD | 42.036% |
Össur hf. | 396.18 Million USD | 99.897% |
Zecotek Photonics Inc. | 3.46 Million USD | 88.228% |
QHSLab, Inc. | 961.65 Thousand USD | 57.627% |
Wellstar International, Inc. | 1.79 Million USD | 77.295% |
Össur hf. | 396.18 Million USD | 99.897% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 21.77 Million USD | 98.129% |
Escalon Medical Corp. | 5.25 Million USD | 92.239% |
Aurora Spine Corporation | 8.65 Million USD | 95.293% |
BrainsWay Ltd. | 28.01 Million USD | 98.546% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 9.56 Million USD | 95.74% |
Hamilton Thorne Ltd. | 33.57 Million USD | 98.786% |
Vivos Inc. | 2.78 Million USD | 85.38% |
MicroPort Scientific Corporation | 1.04 Billion USD | 99.961% |
Kelyniam Global, Inc. | 2.27 Million USD | 82.09% |
REMSleep Holdings, Inc. | 1.01 Million USD | 59.85% |
CYduct Diagnostics, Inc. | 435.5 Thousand USD | 6.433% |
Nanomix Corporation | 8.36 Million USD | 95.13% |
Theraclion SA | 7.43 Million USD | 94.523% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 1.29 Million USD | 68.524% |
Positron Corporation | 1 Million USD | 59.546% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.11 Million USD | 86.899% |
Lombard Medical, Inc. | 30.29 Million USD | 98.655% |
ALR Technologies Inc. | 6.33 Million USD | 93.569% |
Stratec SE | 46.32 Million USD | 99.12% |
Vycor Medical, Inc. | 1.27 Million USD | 68.052% |
Heart Tronics, Inc. | 14.46 Million USD | 97.182% |
Nu-Med Plus, Inc. | 120.52 Thousand USD | -238.089% |
Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -97.407% |
SANUWAVE Health, Inc. | 14.15 Million USD | 97.12% |
VMS Rehab Systems, Inc. | 63.63 USD | -640297.611% |
Guided Therapeutics, Inc. | 3.49 Million USD | 88.334% |
Ingen Technologies, Inc. | 1.88 Million USD | 78.351% |
Odyssey Group International, Inc. | -14.26 Million USD | 102.857% |
United American Healthcare Corporation | 59 Thousand USD | -590.653% |
Capital Group Holdings, Inc. | 634.68 Thousand USD | 35.798% |
ADM Tronics Unlimited, Inc. | 1.69 Million USD | 75.968% |
Urologix, Inc. | 10.09 Million USD | 95.962% |
Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 67.745% |
Nexeon MedSystems Inc. | 5.94 Million USD | 93.15% |
SS Innovations International, Inc. | 21.38 Million USD | 98.094% |
Qualis Innovations, Inc. | 230.24 Thousand USD | -76.982% |
Smith & Nephew plc | 3.46 Billion USD | 99.988% |
NIOX Group Plc | 22.27 Million USD | 98.171% |
Fuse Medical, Inc. | 10.35 Million USD | 96.063% |
Broncus Holding Corporation | 38.15 Million USD | 98.932% |
Brain Scientific Inc. | 9.66 Million USD | 95.783% |
Pressure BioSciences, Inc. | 10.3 Million USD | 96.045% |
Health Logic Interactive Inc. | 60.69 Thousand USD | -571.332% |